About
Antibacterial drug
Areas of Focus
Categories
Small Molecule Pharmaceutical
Clinical Trials (8)
View allTotal Trials
8
As Lead Sponsor
8
As Collaborator
0
Total Enrollment
533
By Phase
PHASE2: 3PHASE1: 5
By Status
COMPLETED: 7TERMINATED: 1
Clinical Trials Pipeline8 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
Today
Hover over trial bars to see details
Recent Trials
NCT01928433Lead Sponsor
Finafloxacin for the Treatment of cUTI and/or Acute Pyelonephritis
PHASE2Completed
225 participants
Started: Dec 31, 2012 · Completed: Oct 31, 2015
NCT01907867Lead Sponsor
Pharmacokinetic Profile in Plasma and Epithelial Lining Fluid of Finafloxacin
PHASE1Completed
18 participants
Started: Jan 31, 2012 · Completed: Feb 29, 2012
NCT01910883Lead Sponsor
Safety and Tolerability of Single and Multiple Intravenous Doses of Finafloxacin in Healthy Subjects
PHASE1Completed
58 participants
Started: Sep 30, 2010 · Completed: Mar 31, 2012
NCT01904162Lead Sponsor
Effect of Age and Gender on the PK and Tolerability of Finafloxacin
PHASE1Completed
40 participants
Started: Feb 28, 2010 · Completed: Feb 28, 2010
NCT00722735Lead Sponsor
Finafloxacin 300 mg Twice a Day (b.i.d.) Versus Ciprofloxacin 250 mg Twice a Day (b.i.d) in Patients With Lower Uncomplicated UTI (uUTI)
PHASE2Completed
36 participants
Started: Oct 31, 2008 · Completed: Apr 30, 2009
Locations (1)
Headquarters
Berlin, Germany
Map
Loading map...